Inspire Medical Systems, Inc.
INSP · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $5,517,465 | $5,960,937 | $7,070,712 | $6,272,121 |
| - Cash | $150,150 | $185,537 | $441,592 | $214,467 |
| + Debt | $31,793 | $24,846 | $8,872 | $34,095 |
| Enterprise Value | $5,399,108 | $5,800,246 | $6,637,992 | $6,091,749 |
| Revenue | $802,804 | $624,799 | $407,856 | $233,394 |
| % Growth | 28.5% | 53.2% | 74.7% | – |
| Gross Profit | $679,818 | $528,223 | $341,741 | $200,115 |
| % Margin | 84.7% | 84.5% | 83.8% | 85.7% |
| EBITDA | $65,025 | -$17,060 | -$40,733 | -$38,624 |
| % Margin | 8.1% | -2.7% | -10% | -16.5% |
| Net Income | $53,509 | -$21,153 | -$44,881 | -$42,042 |
| % Margin | 6.7% | -3.4% | -11% | -18% |
| EPS Diluted | 1.75 | -0.72 | -1.6 | -1.54 |
| % Growth | 343.1% | 55% | -3.9% | – |
| Operating Cash Flow | $130,246 | $24,653 | $11,569 | -$20,119 |
| Capital Expenditures | -$39,123 | -$23,629 | -$9,096 | -$4,668 |
| Free Cash Flow | $91,123 | $1,024 | $2,473 | -$24,787 |